POST Online Media Lite Edition



 

UK government to compensate against severe coronavirus vaccine side effects

Christian Fernsby |
The government is taking this precautionary step in advance of a rollout of an authorised coronavirus vaccine and in line with other immunisation programmes.

Article continues below




In advance of a rollout of an authorised coronavirus vaccine and in line with other immunisation programmes, the government is taking the precautionary step to ensure that, in the very rare possibility where someone is severely disabled as a result of taking a coronavirus vaccine, they can access financial assistance through the Vaccine Damage Payments Scheme (VDPS).

No safety concerns have been reported in vaccines authorised for use following rigorous clinical trials involving tens of thousands of people and extensive analysis of the vaccine’s safety, quality and effectiveness by experts from the Medicines and Healthcare products Regulatory Agency (MHRA).

Pfizer BioNTech’s vaccine is now the first coronavirus vaccine to be authorised for use in the UK, and the MHRA will keep safety under continual review.

Adding diseases to the VDPS is not new and numerous diseases have been added as successive governments have rolled out more immunisation programmes, such as HPV and Meningitis B..

Generally, only those who were administered vaccines as part of a childhood immunisation programme are covered under the VDPS.

However, because coronavirus vaccines will be rolled out to a large proportion of the adult population, the government will amend the eligibility requirements, ensuring adults who are administered a coronavirus vaccine in the UK or Isle of Man, or as part of an armed forces medical treatment, will be covered by the scheme too.

This is not a novel approach. Currently, polio, rubella, meningococcal group C, HPV and meningococcal group W (up to age 26) are also exempt from the age requirement, as these vaccines were primarily offered to adults.

Deputy Chief Medical Officer for England Professor Jonathan Van-Tam said: "We are extremely confident in the effectiveness and safety of our immunisation programmes. We will not be rolling out a coronavirus vaccine unless it has met robust standards of safety, effectiveness and quality and authorised for use by the medicines regulator, the MHRA.

"The UK has one of the most comprehensive immunisation programmes in the world, and sensible routine precautions such as these form a huge part of our global-leading standards in safety."

The VDPS is a safety net to help ease the burden on individuals who have in extremely rare circumstances experienced harm due to receiving a government recommended vaccine. It is not a compensation scheme. Rather, it provides a one-off, tax free lump sum currently £120,000 for those suffering a severe disability as a result of a vaccine against a disease listed under the Vaccine Damage Payments Act.


What to read next

Trump announces new vaccine contract
Trudeau pledges over 300 mln USD for coronavirus vaccine access program
Germany to start coronavirus vaccinations by mid-December